Balanced Rock Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Balanced Rock Investment Advisors's LLY Position: Q1 2026 in Review
Balanced Rock Investment Advisors increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $34.5K and bringing the position to 340 shares worth $313K. The position accounts for 0.22% of the portfolio, ranked #81.
Balanced Rock Investment Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $329K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Balanced Rock Investment Advisors held 340 shares of Eli Lilly worth $313K as of Q1 2026.
- Balanced Rock Investment Advisors bought 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
- Eli Lilly made up 0.22% of Balanced Rock Investment Advisors's portfolio in Q1 2026, its #81 holding.
- Balanced Rock Investment Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
- Balanced Rock Investment Advisors's Eli Lilly position peaked at $329K in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Balanced Rock Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.